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RAC1/P38 MAPK Signaling Pathway Controls
b1 Integrin±Induced Interleukin-8 Production
in Human Natural Killer Cells
(reviewed in Seger and Krebs, 1995; Su and Karin, 1996;
Robinson and Cobb, 1997). Unlike Erk and Jnk, very
few data are available on the activation of p38 MAPK
following integrin stimulation.
In mammalian cells, p38 MAPK, the Hog1p homolog,
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pathway have not been fully identified yet. However, theVia delle Messi d'oro 156
Rho family GTPases Rac1 and Cdc42 (reviewed in VanRome 00158
Aelst and D'Souza-Schorey, 1997; Mackay and Hall,Italy
1998) and the cytoplasmic kinase Pak1 (Bagrodia et al.,
1995; Zhang et al., 1995) have been implicated in the
control of the p38 MAP kinase signaling pathway.Summary
p38 MAPK is implicated in the regulation of inflamma-
tory and immune responses by promoting the expres-The MAP kinase (MAPK) p38 plays a key role in regulat-
sion of several cytokines and controlling cell prolifera-ing inflammatory responses. Here, we demonstrate
tion and death. To date, no evidence on the involvementthat b1 integrin ligation on human NK cells results in
of the p38 MAPK signaling pathway in the regulation ofthe activation of the p38 MAPK signaling pathway,
natural killer (NK) cell activation and functions iswhich is required for integrin-triggered IL-8 produc-
available.tion. In addition, we identified some of the upstream
NK cells belong to a distinct lineage of lymphocytesevents accompanying the b1 integrin±mediated p38
that play an important role in the early phase of immuneMAPK activation, namely, the activation of the Rac
responses against certain viruses, parasites, and micro-guanine nucleotide exchange factor (GEF) p95 Vav,
bial pathogens by exhibiting cytotoxic functions andthe small G protein Rac1, and the cytoplasmic kinases
secreting a number of cytokines (reviewed in Scott andPak1 and MKK3. Finally, we provide direct evidence
Trinchieri, 1995; Biron, 1997). NK cells circulate in thethat p95 Vav and Rac control the activation of p38
peripheral blood, are resident in the spleen, liver, lungs,MAPK triggered by b1 integrins.
and intestine, and rapidly accumulate in the parenchi-
mas of several organs during inflammation, tumor
Introduction growth, and invasion.
Recent evidence indicates that NK cells can also be
During immune and inflammatory responses, leukocyte involved in the recruitment of various leukocyte cell
migration across endothelium and into the tissues is types based on their capacity of synthesizing several
largely governed by a large number of chemoattractants chemokines, including IL-8 (Saito et al., 1994; Somersalo
and adhesion receptors. et al., 1994). IL-8 is the most throughly characterized
Integrins are a family of heterodimeric ab receptors member of the C-X-C or a-chemokine family. IL-8 is a
that mediate cell adhesion to extracellular matrix com- potent polymorphonuclear cell chemoattractant, al-
ponents and cell to cell interactions (reviewed in Hynes, though it can affect migration of additional effector cells,
1992; Giancotti and Mainiero, 1994). In recent years, a such as T lymphocytes, monocytes, basophils, and eo-
rapid accumulation of data has demonstrated that sinophils, into the target tissue. In addition to migration,
cross-linking of integrins by their ligands can lead to IL-8 induces neutrophil adhesiveness, degranulation,
activation of a variety of signaling pathways (reviewed and respiratory burst. Besides its central role in inflam-
in Defilippi et al., 1997). Interestingly, coupling of integrin mation, IL-8 has also been implicated in other biological
receptors to mitogen-activated protein kinase (MAPK) processes such as angiogenesis and hematopoiesis (re-
pathways has been reported (Chen et al, 1994; Wary et viewed in Baggiolini et al., 1994; Baggiolini et al., 1997;
al., 1996; Mainiero et al., 1997, 1998). At least three Rollins, 1997).
distinct groups of MAPKs have been identified in mam- We have previously shown that peripheral blood hu-
mals, including extracellular signal-regulated kinases man NK cells express b1 integrin receptors and that their
(Erk1 and Erk2), c-Jun N-terminal kinase (Jnk), and p38 engagement transduces intracellular signals leading to
activation of the Fak-related nonreceptor tyrosine ki-
nase Pyk-2, tyrosine phosphorylation of paxillin (Gis-§ To whom correspondence should be addressed (e-mail: fmainiero@
axrma.uniroma1.it). mondi et al., 1997), elevation of intracellular calcium,
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Figure 1. Ligation of b1 Integrin FN Recep-
tors Induces IL-8 Chemokine Production in
Human NK Cells
(A) Human NK cells were left untreated (C) or
stimulated with anti-b1 (4B4), anti-b1 (TS2/
16) F(ab9)2 fragments, anti-CD16 (B73.1), anti-
CD56 (C218) mAb, FN, or BSA for 24 hr at
378C in a 5% CO2 atmosphere in duplicate
wells of flat-bottom plates (10 3 106 cells/
well) in medium containing 1% BSA. After in-
cubation, cell-free supernatants were col-
lected, and IL-8 concentration was quantitated
by ELISA. These results are representative of
one out of three independent experiments.
(B) Total RNA was extracted from human NK
cells left untreated (-) or stimulated with anti-
b1 (4B4) or anti-CD56 (C218) mAb for the indi-
cated times at 378C, and RT-PCR with
IL-8 or b-actin-specific primers was performed. PCR products were electrophoresed on a 1.5% agarose gel, and the gels were then stained
with ethidium bromide and photographed. These results are representative of one out of three independent experiments.
and costimulation of NK cytotoxic functions (Palmieri et expression (Lee et al., 1994). To determine the potential
role of p38 MAPK in the regulation of integrin-inducedal., 1995). More recently, we demonstrated that ligation
of b1 integrins on human NK cells results in the stimula- IL-8 production, we initially used SB203580, a pyridinyl
imidazole drug compound that specifically binds to p38tion of the Ras/ERK signaling pathway, which controls
interferon (IFN)g production (Mainiero et al., 1998). MAPK and reversibly blocks its enzymatic activity (Lee
et al., 1994). A dose-dependent inhibition of IL-8 produc-Despite the increasingly prominent role of chemo-
kines in the regulation of integrin function, relatively little tion was obtained in b1 integrin±stimulated NK cells in
the presence of different concentrations of SB203580is known about the ability of integrins to affect chemo-
kine gene expression and the signaling pathways that (Figure 2A). SB203580, at the concentration of 1 mM,
also abrogated FN-induced IL-8 production (Figure 2C).may mediate these effects.
We demonstrate here that ligation of b1 integrins, By contrast, b1 integrin±induced IFNg production was
not significantly affected even by the highest concentra-namely fibronectin (FN) receptors, on human NK cells
results in the production of the proinflammatory chemo- tion of SB203580 (10 mM) (Figure 2B). In addition, no
inhibition of IL-8 production was obtained by using thekine IL-8, which requires activation of the Rac1/p38
MAPK signaling pathway. specific MEK-1 inhibitor PD98059, which completely ab-
rogated IFNg production as previously shown (Mainiero
et al., 1998) (Figures 2A and 2B). The presence of theseResults
inhibitors did not affect human NK cell viability at the
time point (24 hr) when culture supernatants were har-Ligation of b1 Integrin FN Receptors on Human NK
Cells Stimulates IL-8 Production that Requires vested to determine cytokine production (data not
shown).p38 MAPK
We first examined if ligation of b1 integrins on human In order to provide direct evidence on the functional
requirement for p38 MAPK in b1 integrin±mediated IL-8NK cells causes IL-8 production by testing the presence
of this chemokine in the supernatants of human NK cells production, we attempted to perturb p38 expression
using antisense oligodeoxynucleotides (ODNs) (Nagatastimulated with anti-b1, anti-b1 F(ab9)2, anti-CD16, or
anti-CD56 control mAb. b1 integrin cross-linking re- et al., 1998). Human NK cells were incubated with anti-
sense (AS) and complementary sense (S) ODNs of p38sulted in high levels of IL-8 production, comparable to
those induced by engagement of CD16, one of the major and then left untreated or stimulated with anti-b1 mAb.
Western blot analysis showed that p38 was greatly di-NK activating receptors; by contrast, treatment of hu-
man NK cells with anti-CD56 mAb did not stimulate IL-8 minished in cells exposed to AS-ODN when compared
to cells exposed to S-ODN or to untreated control (Figureproduction. This event did not result from the engage-
ment of NK cell FcgRIII (CDI6) in that anti-b1 F(ab9)2 2E). Decreased p38 expression resulted in complete
inhibition of b1 integrin±induced IL-8 production, indi-fragments were also effective (Figure 1A).
We then tested whether FN, which interacts with a4b1 cating that p38 MAPK is functionally involved in this
event (Figure 2D).and a5b1 on human NK cells (Gismondi et al., 1991),
may also induce IL-8 production. As shown in Figure
1A, treatment with FN, but not BSA, induced IL-8 pro-
duction at significant levels. We also confirmed this re- The p38 MAPK Is Activated by Ligation of b1
Integrin FN Receptors on Human NK Cellssult at mRNA level. RT-PCR analysis, performed on total
RNA from human NK cells, showed that b1 integrin, but We directly tested if ligation of b1 integrins on human
NK cells could result in p38 MAPK activation. Humannot CD56 antigen ligation, induced IL-8 mRNA expres-
sion that is maximal at 1.5 hr and still persistent at 4 hr NK cells were stimulated with anti-b1, anti-b1 F(ab9)2,
anti-CD16, or anti-CD56 mAb, and phosphorylation ofafter stimulation (Figure 1B).
Activation of p38 MAPK has been implicated among p38 MAPK was examined using an antibody against the
active, phosphorylated form of p38 MAPK. Western blotthe signaling pathways leading to regulation of cytokine
Integrins Control IL-8 via RAC1/P38 in NK
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Figure 2. b1 Integrin±Induced IL-8 Chemokine Production in Human NK Cells Requires p38 MAPK
(A±C) Human NK cells were incubated for 30 min at 378C with different concentrations of SB203580 or PD098059 and then stimulated with
anti-b1 (4B4), anti-CD56 (C218) mAb, FN, or BSA for 24 hr at 378C in a 5% CO2 atmosphere in duplicate wells of flat-bottom plates (10 3 106
cells/well) in medium containing 1% BSA. After incubation, IL-8 or IFNg concentrations were quantitated by ELISA in the cell-free supernatants.
(D and E) Human NK cells were incubated with p38 AS or S-ODNs for 72 hr and then left untreated or stimulated with anti-b1 (4B4) mAb for
24 hr at 378C in a 5% CO2 atmosphere in duplicate wells of flat-bottom plates (10 3 106 cells/well) in medium containing 1% BSA. After
incubation, IL-8 concentration was quantitated by ELISA in the cell-free supernatants (D), and the amount of p38 was examined on total cell
lysates by Western blot analysis; as loading controls, the amounts of p44/42 MAPK proteins are shown on the bottom (E). These results are
representative of one out of three independent experiments.
analysis showed that b1 integrin stimulation causes sig- at 15 min after stimulation. No changes in Pak1 activity
were observed in untreated or anti-CD56 mAb-treatednificant activation of p38 MAPK at levels comparable to
those induced by engagement of CD16. By contrast, NK cells used as control (Figure 4A).
We also investigated if b1 integrin cross-linking onanti-CD56 control mAb treatment did not result in any
significant activation of p38 MAPK. In addition, treat- human NK cells could induce activation of MKK3
and/or MKK6. Western blot experiments showed thatment with FN, but not BSA, induced activation of p38
MAPK (Figure 3A). The analysis of the p38 MAPK activa- b1 integrin cross-linking causes significant levels of acti-
vation of MKK3. The time course reveals that it is rapid,tion time course shows that it is rapid, is still persistent
at 30 min, and returns to basal levels at 90 min after peaks at 5 min, is still persistent at 30 min, and returns
to basal levels after 90 min. In contrast, anti-CD56 con-stimulation (Figure 3B). Similar results were obtained by
analyzing p38 MAPK activation by in vitro kinase assay trol mAb treatment did not result in any significant acti-
vation of MKK3 (Figure 4B). The levels of b1 integrin±on p38 immunoprecipitates, using GST-ATF-2 as sub-
strate (Figure 3C). The presence of SB203580, at the triggered MKK3 phosphorylation were comparable to
those obtained with anisomycin or sorbitol (data notsame concentrations that abolished b1 integrin±induced
IL-8 production, completely inhibited p38 but not Erk shown). By contrast, no activation of MKK6 was ob-
served in b1 integrin±stimulated human NK cells, al-and Jnk MAPK activation (Figure 3D).
though MKK6 stimulation was readily induced by aniso-
mycin and sorbitol (Figure 4C).Pak1 and MKK3 Are Activated by b1 Integrin
Cross-Linking on Human NK Cells These data indicate that activation of p38 MAPK
through ligation of b1 integrins on human NK cells isThe mammalian protein-serine kinase Pak1, MKK3, and
MKK6 have been implicated in the control of the p38 associated with significant and persistent activation of
Pak1 and MKK3, but not MKK6, strongly suggestingMAPK activity (Bagrodia et al., 1995; DeÂ rijard et al., 1995;
Zhang et al., 1995; Raingeaud et al., 1996; Enslen et al., their involvement in this event.
1998). We examined if b1 integrin cross-linking induces
Pak1 activation in human NK cells. An in vitro kinase Cross-Linking of b1 Integrins on Human NK Cells
Activates Rac1, which Controls p38assay performed on anti-Pak1 immune complexes iso-
lated from NK cells stimulated with anti-b1 or anti-CD56 MAPK Activation
It is well known that the serine/threonine kinase Pak1Mab showed that Pak1 activity was significantly in-
creased following b1 integrin ligation, as visualized by binds to GTP-bound Rac1 (Martin et al., 1995). Despite
a large amount of evidence implicating Rac1 in integrin-phosphorylation of the exogenous substrate MBP. Pak1
activation was already maximal at 5 min and declined mediated functional responses (D'Souza-Schorey et al.,
Immunity
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Figure 3. Activation of p38 MAPK by b1 Inte-
grin Cross-Linking on Human NK Cells
(A) Human NK cells were left untreated (-) or
stimulated with anti-b1 (4B4), anti-b1 (TS2/
16) F(ab9)2 fragments, anti-CD16 (B73.1), anti-
CD56 (C218) Mab, FN, or BSA for the 15 min
at 378C, and p38 MAPK activation was exam-
ined by Western blot analysis performed on
total cell lysates. As loading controls, the
amounts of p38 are shown on the bottom.
(B and C) Human NK cells were left untreated
(-) or stimulated with anti-b1 (4B4) mAb for
the indicated times at 378C, and p38 MAPK
activation was examined as above (B) or on
p38 immunoprecipitates by in vitro kinase
assay using GST-ATF-2 as substrate (C). As
loading controls, the amounts of p38 are
shown on the bottom.
(D) Human NK cells were incubated for 30
min at 378C with different concentrations of
SB203580 and then stimulated with anti-b1
(4B4) or anti-CD56 (C218) mAb for 10 min at
378C, and p38, Erk, and Jnk MAPK activation
were examined by Western blot analysis per-
formed on total cell lysates. As loading con-
trols, the amounts of p38, Erk, and Jnk MAPK
proteins are shown. These results are repre-
sentative of one out of three independent ex-
periments.
1998; Price et al., 1998), no direct demonstration of Rac1 Cross-Linking of b1 Integrins on Human NK Cells
Induces Vav Tyrosine Phosphorylation, which Controlsactivation upon integrin receptor triggering has been
provided so far. Thus, we performed GTP-loading exper- p38 MAPK Activation and IL-8 Production
The protooncogene p95 Vav, selectively expressed iniments to examine if ligation of b1 integrins on human
NK cells results in the activation of Rac1. After in vivo hematopoietic cells, acts as GEF for the low molecular
weight Rho-family GTPase Rac1, and its GEF activity islabeling with 32P-orthophosphate, human NK cells were
stimulated with anti-b1 or anti-CD56 mAb. Chromato- regulated by PTK-dependent tyrosine phosphorylation
(Crespo et al., 1997). To investigate the possible involve-graphic analysis of nucleotides bound to Rac1 indicated
that b1 integrin stimulation results in a 2-fold increase ment of Vav in b1 integrin±induced Rac1 activation, hu-
man NK cells were stimulated with anti-b1 or anti-CD56in the proportion of GTP-bound Rac1 (from 27% to 55%).
Anti-CD56 mAb-treated control sample showed a p21 mAb, and anti-Vav immunoprecipitates were examined
by immunoblotting with anti-pTyr mAb. Marked tyrosineRac1 GTP/GDP1GTP ratio comparable to that of the
untreated sample (Figure 5A). phosphorylation of Vav was detected after b1 integrin
cross-linking; Vav phosphorylation was rapid, peakedTo directly assess the role of Rac1 in b1 integrin±
induced activation of p38 MAPK, human NK cells were at 5 min, and declined at 15 min. No changes in the
phosphorylation status of Vav were observed in anti-infected with recombinant vaccinia virus encoding wild-
type (WT) Rac1 or dominant-negative N17-Rac1. In- CD56 mAb-treated NK cells used as control (Figure 6A).
These results indicate that Vav undergoes tyrosinefected human NK cells were then left untreated or stimu-
lated with anti-b1 mAb, and phosphorylation of p38 phosphorylation in b1 integrin±stimulated NK cells and
strongly suggest that its GEF activity can be involvedMAPK was examined as above. Western blot analysis
showed that dominant-negative N17-Rac1 completely in- in b1 integrin±mediated p21 Rac1 and p38 MAP kinase
activation.hibits b1 integrin±induced p38 MAPK activation, whereas
wild-type Rac1 overexpression causes a slight increase In order to provide direct evidence on the functional
requirement for Vav in b1 integrin±mediated p38 MAPKin the b1 integrin±induced p38 MAPK activation (Figure
5B). In addition, infection with wild-type virus alone (WR) activation and IL-8 production, we attempted to perturb
Vav expression using ODNs (Galandrini et al., 1999).did not affect p38 activation.
These data indicate that the small G protein Rac1 Human NK cells were incubated with Vav AS- or S-ODNs
and then left untreated or stimulated with anti-b1 mAb.controls b1 integrin±induced p38 MAP kinase activation
on human NK cells. Western blot analysis showed that immunodetectable
Integrins Control IL-8 via RAC1/P38 in NK
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activation of Rac GEF p95 Vav, the small G protein Rac1,
and the cytoplasmic kinases Pak1 and MKK3. Finally,
our data directly demonstrate that p95 Vav and Rac1
control the activation of p38 MAPK triggered by b1 inte-
grins.
p38 MAPKs were initially characterized as enzymes
activated in response to stresses such as heat, cold, UV
irradiation, osmolar shock, and to the proinflammatory
cytokines, tumor necrosis factor (TNF)a, and interleu-
kin-1 (IL-1) (Lee et al., 1994; Su and Karin, 1996). Cross-
linking of the T cell receptor (TCR), CD28, or Fas on
proliferating T cells, or cross-linking of the B cell recep-
tor (BCR) or CD40 on freshly isolated or LPS-activated
splenic B cells (Salmon et al., 1997; Craxton et al., 1998;
Zhang et al., 1999) also results in rapid activation of
p38 MAPK, and this event has been implicated in the
regulation of cytokine production and apoptosis.
No evidence on the role of p38 MAPK activation in
the regulation of NK cell functions has been provided
so far. Moreover, although several studies have de-
scribed the ability of integrins to activate ERK and JNK
(Chen et al, 1994; Wary et al., 1996; Mainiero et al., 1997,
1998), it is unknown whether these receptors may also
initiate p38 MAPK cascade. The results of this study
demonstrate that ligation of b1 integrin FN receptors on
human NK cells stimulates the phosphorylation and the
enzymatic activity of p38 MAPK to levels comparable
to those induced by CD16 engagement.
Control of p38 MAPK activation has been shown to
involve Rac and Cdc42, members of the Rho-related
small GTPase family that are implicated in a wide spec-
trum of cellular processes, namely cytoskeletal or-
ganization, membrane trafficking, transcription factor
Figure 4. Activation of Pak1 and MKK3, but Not MKK6, by b1 Inte- regulation, cell cycle progression, and cellular transfor-
grin Cross-Linking on Human NK Cells
mation (reviewed in Van Aelst and D'Souza-Schorey,
(A) Human NK cells were left untreated (-) or stimulated with anti- 1997; Mackay and Hall, 1998). The role of Rac1 in regu-
b1 (4B4) or anti-CD56 (C218) mAb for the indicated times at 378C.
lating transcription factor activity through its ability toOn anti-Pak1 immunoprecipitates, an in vitro kinase assay was per-
activate MAPK cascades has been more extensivelyformed using MBP as substrate. As loading controls, the amounts
studied on the Jnk pathway (Coso et al., 1995; Mindenof Pak1 immunoprecipitated are shown on the bottom. These results
are representative of one out of three independent experiments. et al., 1995), whereas relatively little is known about Rac-
(B and C) Human NK cells were left untreated (-) or stimulated with mediated regulation of the p38 MAPK pathway. Rac1
anti-b1 (4B4) or anti-CD56 (C218) mAb for the indicated times or has been found to be coupled to and regulate the activity
with anisomycin ([AN];10 mg/ml, 45 min) or sorbitol ([Srb]; 0.5 M, 30 of p38 MAPK in response to inflammatory cytokinesmin) at 378C, and activation of MKK3 or MKK6 was examined by
such as IL-1 (Bagrodia et al., 1995). Moreover, recentWestern blot analysis performed on total cell lysates. As loading
evidence shows impaired p38 MAPK phosphorylationcontrols, the amounts of MKK3 or MKK6 are shown on the bottom.
induced by fLMP stimulation in Rac-2-deficient neutro-These results are representative of one out of three independent
experiments. phils (Roberts et al., 1999). Consistent with these stud-
ies, by the use of recombinant vaccinia virus encoding
the dominant-negative N17-Rac1 mutant, we show that
Vav was greatly diminished in cells exposed to AS-ODN Rac1 controls b1 integrin±mediated activation of p38
when compared to cells exposed to S-ODN or to un- MAPK. Moreover, we provide direct demonstration of
treated control. AS-ODN but not S-ODN treatment mark- the ability of integrins to induce GDP/GTP exchange
edly reduced b1 integrin±induced p38 MAPK activation activity on endogenous Rac1, although several studies
as well as IL-8 production, indicating that Vav activity using transient or inducible expression of either acti-
is functionally involved in these events (Figures 6B and 6C). vated or dominant-negative Rac1 mutants have sug-
gested a role for Rac in the formation of membrane
Discussion ruffles and lamellipodia, as well as in the integrin-medi-
ated cell spreading on FN (D'Souza-Schorey et al., 1998;
Here, we demonstrate that b1 integrin ligation on human Price et al., 1998).
peripheral blood NK cells results in the activation of the We have also shown the potential upstream signaling
Rac/p38 MAPK signaling pathway that is required for events leading to b1 integrin±mediated Rac1/p38 MAPK
integrin-triggered IL-8 production. In addition, we identi- activation. Rac1 activation paralleled the tyrosine phos-
fied some of the upstream events accompanying the phorylation of GEF for Rac1, Vav (Crespo et al., 1997).
Like dominant-negative N17-Rac1 infected human NKb1 integrin±mediated p38 MAPK activation, namely the
Immunity
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Figure 5. Cross-Linking of b1 Integrins on
Human NK Cells Activates Rac1, which Con-
trols p38 MAP Kinase Activation
(A) TLC of the nucleotides eluted from Rac1
immunoprecipitates of (32P)orthophosphate-
labeled NK cells. Cells were stimulated for 5
min with appropriate doses of anti-b1 (4B4)
or anti-CD56 (C218) mAb at 378C before lysis.
The position at which GTP and GTP stan-
dards run is indicated. Numbers indicate the
molar ratio of GTP over total nucleotides from
quantitation by direct scanning for b radiation
of the same experiment. These results are
representative of one out of three indepen-
dent experiments.
(B) Human NK cells were infected with recom-
binant vaccinia virus encoding wild-type (WT)
Rac1, dominant-negative N17-Rac1, or wild-
type vaccinia virus alone (WR). Infected human NK cells were left untreated (-) or stimulated with anti-b1 (4B4) mAb for 59 at 378C, and p38
activation was examined by Western blot analysis performed on total cell lysates. As loading controls, the amounts of p38 protein are shown
on the center panel. As overexpression control, the amounts of Rac1 protein are shown on the bottom. These results are representative of
one out of three independent experiments.
cells, no b1 integrin±induced p38 MAPK activation was NK cells following interaction with sensitive targets (Ga-
landrini et al., 1999). On the other hand, a role for theobserved in Vav AS-ODN treated cells, further support-
ing a role for Vav in Rac1 activation. Vav tyrosine phos- Fak family kinase Pyk-2 may also be envisaged, as we
have recently demonstrated the ability of b1 integrinsphorylation was previously observed upon aIIbb3 cell
adhesion on fibrinogen or Ab-mediated b1 and b2 inte- to stimulate tyrosine phosphorylation of Pyk-2 in human
NK cells (Gismondi et al., 1997), and Pyk-2 activationgrin ligation in myeloid cells (Cichowski et al., 1996;
Gotoh et al., 1997). At present, no knowledge of the has been reported as a receptor proximal event control-
ling Rac and p38 MAPK activation in response to stressprotein tyrosine kinases (PTKs) responsible for b1 inte-
grin±induced Vav phosphorylation is available. Much ev- stimuli (Tokiwa et al., 1996; Pandey et al., 1999).
Our data also indicate that activation of p38 MAPKidence indicates that PTKs belonging to the Src and the
Syk/Zap-70 families may be implicated in this event. through ligation of b1 integrins on human NK cells is
associated with a significant and persistent activationaIIbb3 stimulates Vav1 tyrosine phosphorylation in a
Syk-dependent manner (Miranti et al., 1998), and associ- of Pak1 and MKK3, strongly suggesting that they are
potential constituents of the p38 MAPK signalingation between tyrosine-phosphorylated Syk and tyro-
sine-phosphorylated Vav has been reported in human pathway.
Figure 6. Ligation of b1 Integrins on NK Cells
Induces Tyrosine Phoshorylation Vav, which
Controls p38 MAPK Activation and IL-8 Pro-
duction
(A) Human NK cells were left untreated (-)
or stimulated with anti-b1 (4B4) or anti-CD56
(C218) mAb for the indicated times at 378C.
Cells were immunoprecipitated with anti-Vav
mAb. Resulting protein complexes were re-
solved by 7% SDS-PAGE and immunoblotted
with anti-pTyr. As loading controls, the
amounts of Vav immunoprecipitated are
shown on the bottom. These results are rep-
resentative of one out of three independent
experiments.
(B) Human NK cells were exposed to Vav-AS
or -S ODNs for 56 hr and then left untreated
or stimulated with anti-b1 (4B4) mAb. Vav ex-
pression and p38 activation were examined
by Western blot analysis performed on total
cell lysates. As loading controls, the amounts
of Syk and p38 MAPK proteins are shown.
(C) Human NK cells were incubated with Vav
ODNs and stimulated as above for 24 hr at
378C in a 5% CO2 atmosphere in duplicate
wells of flat-bottom plates (10 3 106 cells/
well) in medium containing 1% BSA. After in-
cubation, IL-8 concentration was quantitated
by ELISA in the cell-free supernatants.
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strongly suggest that MKK3 is responsible for the inte-
grin-triggered p38 activation. The MAPK kinase kinases
(MKKKs) involved in the activation of MKK3 through
integrins are presently unknown, and further studies are
required to define their function and specificity.
Finally, our results demonstrate that the ligation of b1
integrins on human NK cells results in the stimulation
of IL-8 production that is under the control of p38 MAPK
activation, as shown by the use of the specific synthetic
inhibitor SB203580 and p38 AS-ODN. Moreover, consis-
tent with the finding that Vav controls p38 MAPK activa-
tion, we demonstrated a role for Vav in b1 integrin±
induced IL-8 production using Vav AS-ODN. As in our
study, activation of p38 MAPK was found indispensable
for the neutrophil IL-8 production stimulated by granulo-
cyte-macrophage colony stimulating factor (GM-CSF),
LPS, as well as TNFa, but not for that induced by phorbol
myristate acetate (PMA) or ionomycin (Zu et al., 1998).
The mechanisms involved in the p38 MAPK-mediated
IL-8 production by integrins are unknown. It is conceiv-
able, however, that they may be related to the ability of
p38 MAPK to regulate the activity of several transcrip-
tion factors involved in the control of the IL-8 gene pro-
moter including Elk-1, NF-kB, ATF-2, and CREB (Price
et al., 1996; Su and Karin, 1996; Tan et al., 1996; Craxton
et al, 1998).
In sum, the results of this study suggest a model that
Figure 7. The RAC1/P38 MAPK Signaling Pathway Controls b1 Inte-
depicts a Rac1-dependent pathway generated by thegrin±Induced IL-8 Production in Human NK Cells
ligation of b1 integrins on human NK cells leading to
Our model depicts a Rac1-dependent pathway generated by the
p38 MAPK activation that controls the production of theligation of b1 integrins on human NK cells leading to p38 MAPK
proinflammatory chemokine IL-8 (Figure 7). The identityactivation that controls the production of the proinflammatory che-
mokine IL-8. b1 integrin ligation induces tyrosine phosphorylation of PTKs involved in Vav tyrosine phosphorylation and
of the protooncogene p95 Vav, which may catalyze Rac1 activation. of the MKKK(s) that cause MKK3 activation is under
Rac1 activation is associated with b1 integrin±induced activation investigation.
of Pak1 and MKK3 and controls p38 MAPK activation leading to What is the pathophysiological relevance of IL-8 pro-
the production of IL-8.
duced by NK cells in response to b1 integrin stimulation?
Production of IL-8 by NK cells has been previously
reported in response to cytokines such as IL-2 and IL-Pak 1 belongs to a family of closely related serine/
18 (Puren et al., 1998) and upon stimulation throughthreonine kinases that mediate several of the down-
CD16, and IL-8 secreted by activated NK cells has beenstream effects of Rac and Cdc42, including activation
shown to support a4b1 and a5b1-mediated migrationof Jnk and p38 MAPKs, and reorganization of the actin
of T cells (Somersalo et al., 1994). Moreover, decidualcytoskeleton (Bagrodia et al., 1995; Zhang et al., 1995;
NK cells as well as NK cells generated from humanSells and Chernoff, 1997). Rapid activation of Pak1 cata-
duodenal mucosa express IL-8 mRNA and produce IL-8lytic activity is induced by a large number of extracellular
(Saito et al., 1994).ligands including growth factors and inflammatory and
b1 integrins have been shown to control NK cell adhe-chemotactic cytokines and is initiated by the binding of
sion to endothelial cells and migration of NK cells intoGTP-Rac1 or GTP-Cdc42, which promote its autophos-
the normal and neoplastic tissues (Allavena et al., 1991;phorylation (Sells and Chernoff, 1997). Recent evidence
Somersalo and Saksela, 1991; Fogler et al., 1996). More-indicates that cross-linking of CD3/TCR complex or Fas
over, tissue uterine NK cells migrate over a dense hor-on T cells also results in rapid activation of Pak1, and
monally regulated ECM rich in FN and laminin.this event is involved in the regulation of gene expres-
Based on our data, it can be hypothesized that NKsion and apoptosis (Rudel et al., 1998).
cells that enter early into the sites of inflammation, byThe MAPK kinases MKK3 and MKK6, which share
secreting IL-8 upon interaction with activated endothe-80% amino acid identity, are considered upstream acti-
lium or ECM components, may participate in the recruit-vators of the p38 MAPK signaling pathway. Recent data
ment of additional effector cells, such as neutrophilsindicate that the dominant-negative mutant of MKK3 but
and T lymphocytes into the target tissue, thus affectingnot of MKK6 inhibits p38 activity in response to hyperos-
the progression and evolution of the inflammatory re-molarity or methylmetane sulfonate (MMS) (Pandey et
sponse. In the decidua, where NK cells are the predomi-al., 1999), and TNF-induced cytokine and IL-12 is im-
nant population during the early stages of gestation, NKpaired in MKK3-deficient mice production (Lu et al, 1999;
cell±derived IL-8 might contribute to regulation of theWysk et al., 1999). In accordance with these reports,
selective leukocyte access at the maternal/fetal in-our evidence that b1 integrin stimulation on NK cells
causes significant activation of MKK3, but not MKK6, terface.
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Experimental Procedures In Vitro Kinase Assay
To analyze Pak1 activation, cells were extracted with Triton lysis
buffer as above. Endogenous Pak1 was immunoprecipitated withAntibodies and Reagents
Anti-CD16 (B73.1) mAb was kindly provided by Dr. G. Trinchieri anti-Pak1 antibodies and subjected to in vitro kinase assay. The
kinase reaction was initiated by adding to the immunoprecipitate(Wistar Institute, Philadelphia, PA). Anti-CD56 (C218) mAb was gen-
erously provided by Dr. A. Moretta (University of Genoa, Genoa, 25 ml of kinase buffer (25 mM Tris [pH 7.5], 12.5 mM b-glycerophos-
phate, 7.5 mM MgCl2, 20 mM cold ATP, and 0.5 mM sodium orthovan-Italy). Anti-b1 (4B4) was purchased from Coulter Immunology. Anti-
b1 (TS2/16) F(ab9)2 fragments were prepared by proteolytic digestion adate) containing 5 mCi of g[32P]-ATP (4,500 Ci/mmol, ICN) and 2.5
mg of myelin basic protein (MBP) (Sigma). After 30 min of incubationas described previously (Gismondi et al., 1995). The anti-phospho-
tyrosine (anti-pTyr) 4G10 and the anti-Vav mAb were purchased at 308C, the samples were boiled in sample buffer and separated
by SDS-PAGE. The gels were dried, and the 32P-labeled proteinsfrom UBI. The affinity-purified rabbit antisera against Rac1, Pak1,
MKK3, Erk, Jnk, and p38 MAPKs, the goat antiserum against MKK6, were made visible by autoradiography.
To examine p38 MAPK activity, cells were extracted for 30 minand the anti-Syk mAb were obtained from Santa Cruz Biotechnol-
ogy. The affinity-purified rabbit antiserum against mouse Ig was on ice with modified Triton lysis buffer (25 mM Hepes [pH 7.5], 300
mM NaCl, 0.1% Triton X-100, 0.2 mM EDTA, 20 mM b-glycerophos-purchased from Zymed Laboratories. Affinity-purified (Fab9)2 frag-
ments of goat anti-mouse Ig (GAM) were purchased from ICN-Cap- phate, 1.5 mM MgCl2, and 0.5 mM DTT) containing phosphatase
and protease inhibitors. Endogenous p38 MAPK was precipitatedpel. GST-ATF-2 fusion protein was a kind gift of Dr. C. J. Der (Univer-
sity of North Carolina at Chapel Hill). Human plasma FN was with anti-p38 antibodies and subjected to in vitro kinase assay. After
washing, the beads were incubated with 25 ml of kinase buffer aspurchased from GIBCO. The p38 MAPK inhibitor SB203580 was
purchased from Alexis Corporation and the MEK-1 inhibitor PD above containing 1 mg of GST-ATF-2. After 30 min of incubation at
308C, the samples were boiled in sample buffer and separated by098059 from Calbiochem-Novabiochem. Anisomycin and sorbitol
were purchased from Sigma. SDS-PAGE. The gels were dried, and the 32P-labeled proteins were
made visible by autoradiography.
Human NK Cell Preparation and Stimulation
Highly purified (97%) cultured NK cells were obtained by incubating RT-PCR
Total RNA was extracted using RNAfast (Molecular System). For thefor 8 days nylon nonadherent peripheral blood mononuclear cells
(PBMC) (4 3 105 cells) with irradiated (3000 rads) RPMI 8866 cells preparation of cDNA, 1 mg of total RNA was incubated at 428C with
2 ml 103 reaction buffer, 4 ml of 25 mM MgCl2, 2 ml of 10 mM dNTPs,(1 3 105) as previously described (Mainiero et al., 1994).
Human NK cells were stimulated as previously described (Mai- 2 ml of 0.8 mg/ml oligo-p(dT) primer, 50 U RNase inhibitor, and 20 U
AMV reverse transcriptase (Boehringer Mannheim) in a total volumeniero et al., 1998). When indicated, cells were pretreated (30 min at
378C) with the p38 MAPK inhibitor SB203580 or MEK-1 inhibitor PD of 20 ml. A 50 ml solution, containing 5 ml of PCR reaction buffer
103, 3 ml of 25 mM MgCl2, 1 ml of 10 mM dNTPs, 2.5 ml of each098059 before stimulation. In some experiments, before stimulation,
NK cells were infected with recombinant vaccinia virus encoding primer at a concentration of 20 mM, 0.3 ml of 5 U/ml Taq DNA
polymerase (Perkin-Elmer), and 1 ml of the cDNA reverse mixture,wild-type (WT) Rac1, dominant-negative N17-Rac1, or wild-type
vaccinia virus alone (WR), kindly provided by Dr. Leibson (Mayo was subjected to 30 cycles of PCR, consisting of 1 min denaturation
at 948C, 1 min annealing at 638C (IL-8) or 558C (b-actin), synthesisClinic and Fundation, Rochester, Minnesota) (Billadeau et al., 1998).
In brief, semipurified recombinant vaccinia virus was used to infect for 1 min at 728C, and a final elongation at 728C for 5 min. Primer
sequences used for IL-8 were sense, (59-TCTCAGCCCTCTThuman NK cells for 1 hr in serum-free medium at a multiplicity of
infection of 20:1. The remainder of the infection (4 hr) was carried CAAAAACTTCT-39) and antisense, (59-ATGACTTCCAAGCTGGCC
GTGCT-39). Primer sequences used for b-actin were sense, (59-GGGout in RPMI 1640 containing 10% FCS. In other experiments, before
stimulation, NK cells were treated with antisense (AS) and com- TCAGAAGGATTCCTATG-39) and antisense, (59-GGTCTCAAACAT
GATCTGGG-39). PCR products were electrophoresed on a 1.5%plementary sense (S) oligodeoxynucleotides (ODNs) for Vav (Galan-
drini et al., 1999) or p38 (Nagata et al., 1998). The sequences were agarose gel in Tris-borate-EDTA buffer, and the gels were then
stained with ethidium bromide and photographed.as follows: AS-Vav, (59-CATTGGCGCCACAGCTCCAT-39); S-Vav,
(59-ATGGAGCTGTGGCGCCAATG-39); AS-p38, (59-GGCCTCTCCTG
CGACATCTT-39); and S-p38, (59-AAGATGTCGCAGGAGAGGCC-39). IL-8 and IFNg Production Assay
Human NK cells (2.5 3 105/ml) were exposed to ODNs (100 mg/ml) Untreated or treated NK cells were seeded in duplicate wells of flat-
in heat-inactivated (658C for 30') culture medium for 56 or 72 hr. bottom plates (Costar)(10 3 106 cells/well) in medium containing
1% BSA. After incubation (24 hr, 378C in a 5% CO2 atmosphere),
cell-free supernatants were collected.Immunoprecipitation and Immunoblot Analysis
To estimate Rac1 activation, human NK cells were starved for 3 hr IL-8 concentration was quantitated with an ELISA kit (BioSource).
IFNg concentration was quantitated with an ELISA kit (EuroClone,in phosphate-free RPMI and labeled for 3 hr with [32P]-orthophos-
phate (0.5 mCi/ml) (4,500 Ci/mmol, ICN, Biomedicals) in phosphate- Torquay, UK).
free RPMI supplemented with 0.1% phosphate-free fetal calf serum.
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